Skip to content

Clinical trials

Amyloidosis trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Country / region: Taiwan Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20151
20161
20194
20201
20211
20231
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting6
Active, not recruiting1
Enrolling by invitation1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals7
Intellia Therapeutics2
Pfizer2
Alexion Pharmaceuticals, Inc.1
Chang Gung Memorial Hospital1
Eidos Therapeutics, a BridgeBio company1
Ionis Pharmaceuticals, Inc.1
Prothena Biosciences Ltd.1
Taipei Veterans General Hospital, Taiwan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis17
Amyloid Neuropathies, Familial6
Cardiomyopathies5
Polyneuropathies5
Amyloidosis, Familial4
Alzheimer Disease3
Amyloid Neuropathies3
Dementia1
Genetic Diseases, Inborn1
Heart Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.